These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 2187327

  • 1. Treatment of the vertebral crush fracture syndrome with enteric-coated sodium fluoride tablets and calcium supplements.
    Nagant de Deuxchaisnes C, Devogelaer JP, Depresseux G, Malghem J, Maldague B.
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S5-26. PubMed ID: 2187327
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures.
    Gutteridge DH, Stewart GO, Prince RL, Price RI, Retallack RW, Dhaliwal SS, Stuckey BG, Drury P, Jones CE, Faulkner DL, Kent GN, Bhagat CI, Nicholson GC, Jamrozik K.
    Osteoporos Int; 2002 Mar; 13(2):158-70. PubMed ID: 11908491
    [Abstract] [Full Text] [Related]

  • 3. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
    Reeve J, Davies UM, Hesp R, McNally E, Katz D.
    BMJ; 1990 Aug 11; 301(6747):314-8. PubMed ID: 2393738
    [Abstract] [Full Text] [Related]

  • 4. Spontaneous hip fractures in fluoride-treated patients: potential causative factors.
    Gutteridge DH, Price RI, Kent GN, Prince RL, Michell PA.
    J Bone Miner Res; 1990 Mar 11; 5 Suppl 1():S205-15. PubMed ID: 2339631
    [Abstract] [Full Text] [Related]

  • 5. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
    Meunier PJ, Sebert JL, Reginster JY, Briancon D, Appelboom T, Netter P, Loeb G, Rouillon A, Barry S, Evreux JC, Avouac B, Marchandise X.
    Osteoporos Int; 1998 Mar 11; 8(1):4-12. PubMed ID: 9692071
    [Abstract] [Full Text] [Related]

  • 6. Fluoride therapy of type I osteoporosis.
    Devogelaer JP, Nagant de Deuxchaisnes C.
    Clin Rheumatol; 1995 Sep 11; 14 Suppl 3():26-31. PubMed ID: 8846658
    [Abstract] [Full Text] [Related]

  • 7. [New spine and non-spine fractures in 871 women/year treated with oral pamidronate plus calcium and vitamin D supplements].
    Man Z, Otero AB.
    Medicina (B Aires); 1997 Sep 11; 57 Suppl 1():32-6. PubMed ID: 9567352
    [Abstract] [Full Text] [Related]

  • 8. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride.
    Delmas PD, Dupuis J, Duboeuf F, Chapuy MC, Meunier PJ.
    J Bone Miner Res; 1990 Mar 11; 5 Suppl 1():S143-7. PubMed ID: 2339624
    [Abstract] [Full Text] [Related]

  • 9. Sodium fluoride prevents bone loss in primary biliary cirrhosis.
    Guañabens N, Parés A, del Rio L, Roca M, Gómez R, Muñoz J, Rodés J.
    J Hepatol; 1992 Jul 11; 15(3):345-9. PubMed ID: 1447501
    [Abstract] [Full Text] [Related]

  • 10. Fluoride treatment of postmenopausal osteoporosis: age, renal function, and other clinical factors in the osteogenic response.
    Murray TM, Harrison JE, Bayley TA, Josse RG, Sturtridge WC, Chow R, Budden F, Laurier L, Pritzker KP, Kandel R.
    J Bone Miner Res; 1990 Mar 11; 5 Suppl 1():S27-35. PubMed ID: 2339633
    [Abstract] [Full Text] [Related]

  • 11. The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial.
    Reginster JY, Meurmans L, Zegels B, Rovati LC, Minne HW, Giacovelli G, Taquet AN, Setnikar I, Collette J, Gosset C.
    Ann Intern Med; 1998 Jul 01; 129(1):1-8. PubMed ID: 9652994
    [Abstract] [Full Text] [Related]

  • 12. Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride.
    Abitbol V, Mary JY, Roux C, Soulé JC, Belaiche J, Dupas JL, Gendre JP, Lerebours E, Chaussade S, Groupe D'etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
    Aliment Pharmacol Ther; 2002 May 01; 16(5):919-27. PubMed ID: 11966500
    [Abstract] [Full Text] [Related]

  • 13. Acute and long-term effects of zoledronate in adult patients with osteogenesis imperfecta. An observational Spanish study with five years of follow-up.
    Pavón de Paz I, Rosado Sierra JA, Pérez Blanco C, Modroño Móstoles N, Guijarro de Armas G, Navea Aguilera C.
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Feb 01; 66(2):108-116. PubMed ID: 30077631
    [Abstract] [Full Text] [Related]

  • 14. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA, Dussault PM, Thakore-James M, Gagnon D, Baker E, Davis SA, Houranieh AM.
    Epilepsia; 2013 Nov 01; 54(11):1997-2004. PubMed ID: 24010637
    [Abstract] [Full Text] [Related]

  • 15. The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride.
    Hodsman AB, Drost DJ.
    J Clin Endocrinol Metab; 1989 Nov 01; 69(5):932-8. PubMed ID: 2793995
    [Abstract] [Full Text] [Related]

  • 16. Fluoride therapy in postmenopausal osteopenic women: effect on vertebral and femoral bone density and prediction of bone response.
    Pouilles JM, Tremollieres F, Causse E, Louvet JP, Ribot C.
    Osteoporos Int; 1991 Feb 01; 1(2):103-9. PubMed ID: 1790390
    [Abstract] [Full Text] [Related]

  • 17. Effect of cyclical therapy with phosphorus and etidronate on axial bone mineral density in postmenopausal osteoporotic women.
    Miller PD, Neal BJ, McIntyre DO, Yanover MJ, Anger MS, Kowalski L.
    Osteoporos Int; 1991 Jun 01; 1(3):171-6. PubMed ID: 1790405
    [Abstract] [Full Text] [Related]

  • 18. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, Jorgesen B, McGregor C, Schulman L.
    Am J Med; 1996 Sep 01; 101(3):262-9. PubMed ID: 8873487
    [Abstract] [Full Text] [Related]

  • 19. Bone mineral density changes in women with systemic lupus erythematosus.
    Boyanov M, Robeva R, Popivanov P.
    Clin Rheumatol; 2003 Oct 01; 22(4-5):318-23. PubMed ID: 14579164
    [Abstract] [Full Text] [Related]

  • 20. Treatment of osteoporosis with sodium fluoride and calcium: effects on vertebral fracture incidence and bone histomorphometry.
    Lane JM, Healey JH, Schwartz E, Vigorita VJ, Schneider R, Einhorn TA, Suda M, Robbins WC.
    Orthop Clin North Am; 1984 Oct 01; 15(4):729-45. PubMed ID: 6493736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.